| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.6B | $5.5B | $5.9B | $9.1B | $3.4B | $0.5B | $2.1B | $2.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.5B | $1.4B | $2.2B | $5.2B | $1.6B | $0.2B | $1.0B | $0.8B |
| Net Income | $1.7B | $1.1B | $1.6B | $4.1B | $1.2B | — | — | — |
| EPS (Basic) | $2.25 | $1.51 | $2.14 | $5.09 | $2.30 | $0.33 | $1.64 | $1.25 |
| EPS (Diluted) | $2.24 | $1.50 | $2.13 | $5.08 | $2.29 | $0.33 | $1.63 | $1.24 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $24.2B | $21.6B | $20.4B | $20.2B | $19.9B | $4.5B | $4.5B | $4.2B |
| Current Assets | $1.8B | $3.3B | $2.0B | $2.2B | $2.1B | $0.4B | $0.6B | $0.5B |
| Cash & Equivalents | $0.1B | $2.0B | $1.0B | $0.7B | $1.0B | $0.1B | $0.2B | $0.0B |
| Total Liabilities | $9.4B | $8.5B | $7.4B | $7.5B | $8.1B | $2.3B | $2.3B | $2.1B |
| Current Liabilities | $1.6B | $1.1B | $1.7B | $1.2B | $1.2B | $0.4B | $0.3B | $0.3B |
| Stockholders' Equity | $14.8B | $13.1B | $13.0B | $12.7B | $11.7B | $2.2B | $2.2B | $2.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.0B | $2.8B | $3.7B | $5.5B | $1.7B | $0.8B | $1.4B | $1.1B |
| Investing Cash Flow | $-5.6B | $-1.8B | $-2.1B | $-1.7B | $0.3B | $-0.6B | $-0.5B | $-0.3B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.6B | $0.3B | $-1.3B | $-4.1B | $-1.1B | $-0.3B | $-0.7B | $-1.3B |